Prelude Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-270
Closed -$322K 1515
2022
Q2
$322K Sell
270
-231
-46% -$275K 0.01% 879
2022
Q1
$594K Buy
+501
New +$594K 0.02% 616